CSBR
Champions Oncology·NASDAQ
--
--(--)
--
--(--)
CSBR fundamentals
Champions Oncology (CSBR) released its earnings on Dec 15, 2025: revenue was 15.04M (YoY +11.37%), beat estimates; EPS was 0.06 (YoY +20.00%), beat estimates.
Revenue / YoY
15.04M
+11.37%
EPS / YoY
0.06
+20.00%
Report date
Dec 15, 2025
CSBR Earnings Call Summary for Q2,2026
- Revenue Growth: Q2 revenue up 11% YoY to $15M, driven by reduced cancellations
- Profitability: 52% gross margin (vs. 45% last year), $800K adjusted EBITDA
- Strategic Investments:
- $900K in data platform sequencing
- New GM from Illumina to lead data monetization
- Radiolabeling segment scaling with in-house capabilities
- Market Momentum: Pharma R&D outsourcing expected to increase (1/3 of biotechs surveyed)
- Margin Outlook: Core services margin stable at 50-52%, data business could drive margin expansion
EPS
Revenue
Revenue & Expenses
CSBR has released its 2026 Q2 earnings report, with revenue of 15.04M, reflecting a YoY change of 11.46%, and net profit of 237.00K, showing a YoY change of -67.45%. The Sankey diagram below clearly presents CSBR's revenue sources and cost distribution.
Key Indicators
Champions Oncology (CSBR) key financial stats and ratios, covering profitability, financial health, and leverage.
Champions Oncology (CSBR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Champions Oncology (CSBR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Champions Oncology (CSBR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Champions Oncology (CSBR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Champions Oncology (CSBR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did Champions Oncology beat or miss consensus estimates last quarter?What is Champions Oncology's gross profit margin?What factors drove the changes in Champions Oncology's revenue and profit?What is Champions Oncology's latest dividend and current dividend yield?What guidance did Champions Oncology's management provide for the next earnings period?What were the key takeaways from Champions Oncology's earnings call?What does Champions Oncology do and what are its main business segments?What is the market's earnings forecast for Champions Oncology next quarter?
